Neuland Laboratories

Neuland Laboratories P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Neuland Laboratories (NEULANDLAB.NS) as of Oct 31, 2026 is -270.33. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 143.52 — a change of -288.36% (lower).

P/FCF

-270.33

YoY

-288.36%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Neuland Laboratories is 2026 -270.33 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Neuland Laboratories was 2025 143.52 . It decreases by -288.36% lower compared to the previous year.

The Neuland Laboratories P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2019
2,342.62 INR
Jan 1, 2020
1,863.07 INR
Jan 1, 2021
189.59 INR
Jan 1, 2022
-426.81 INR
Jan 1, 2023
92.33 INR
Jan 1, 2024
142.11 INR
Jan 1, 2025
143.52 INR
Jan 1, 2026
-270.33 INR
The Neuland Laboratories P/FCF history
YEARP/FCFYoY
-270.33-288.36%
143.52+0.99%
142.11+53.91%
92.33-121.63%
-426.81-325.12%
189.59-89.82%
1,863.07-20.47%
2,342.62-1,900.21%
-130.13-98.00%
-6,507.04-1,142.97%
623.90-108.91%
-7,003.74-1,530.56%
489.58—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Neuland Laboratories Stock analysis

What does Neuland Laboratories do? Neuland Laboratories Ltd. generates revenue through the manufacture and export of bulk pharmaceutical ingredients and intermediates for the generics industry. The company operates in a single segment focused on active pharmaceutical ingredients (APIs) and allied services, with two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its products include Levetiracetam, Mirtazapine, Ciprofloxacin, Enalapril, Sotalol, and Labetalol, which are supplied to both domestic and international markets. The firm provides end-to-end chemistry solutions for the pharmaceutical industry, covering synthesis of library compounds, NCEs, and advanced intermediates across clinical and commercial stages. The company's primary customers are pharmaceutical firms requiring APIs and intermediates for generic drugs, with a focus on global markets. Neuland Laboratories Ltd. serves as a solution provider for chemistry needs, offering services from early-stage development to commercial production. The business model emphasizes tailored manufacturing services under CMS, alongside standardized GDS products, catering to the full lifecycle of pharmaceutical development and production. Revenue streams are derived from the sale of specific APIs like Levetiracetam and Mirtazapine, as well as custom manufacturing services for complex chemical processes. The firm's dual verticals allow it to address diverse market demands, with GDS targeting cost-effective generic drug production and CMS focusing on specialized, high-value manufacturing solutions for pharmaceutical clients. Neuland Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neuland Laboratories stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Neuland Laboratories is -270.33 in 2026.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Neuland Laboratories changed from 143.52 to -270.33, representing a -288.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Neuland Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Neuland Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Neuland Laboratories

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Neuland Laboratories